Legal & General Group PLC Myriad Genetics Inc Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 246,146 shares of MYGN stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246,146
Previous 251,509 2.13%
Holding current value
$2.46 Million
Previous $6.88 Million 50.98%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$13.17 - $27.03 $70,630 - $144,961
-5,363 Reduced 2.13%
246,146 $3.37 Million
Q3 2024

Feb 28, 2025
SELL
$23.97 - $28.6 $63,160 - $75,361
-2,635 Reduced 1.07%
243,511 $6.66 Million
Q3 2024

Nov 14, 2024
SELL
$23.97 - $28.6 $88,545 - $105,648
-3,694 Reduced 1.45%
251,509 $6.88 Million
Q2 2024

Aug 14, 2024
BUY
$17.98 - $25.47 $84,344 - $119,479
4,691 Added 1.87%
255,203 $6.24 Million
Q1 2024

May 14, 2024
BUY
$17.59 - $23.59 $185,521 - $248,803
10,547 Added 4.4%
250,512 $5.34 Million
Q4 2023

Feb 15, 2024
BUY
$13.91 - $21.32 $212,934 - $326,366
15,308 Added 6.81%
239,965 $4.59 Million
Q3 2023

Nov 14, 2023
SELL
$15.99 - $23.22 $109,227 - $158,615
-6,831 Reduced 2.95%
224,657 $3.6 Million
Q2 2023

Aug 14, 2023
SELL
$17.56 - $23.76 $99,266 - $134,315
-5,653 Reduced 2.38%
231,488 $5.37 Million
Q1 2023

May 15, 2023
SELL
$15.26 - $23.75 $92,155 - $143,426
-6,039 Reduced 2.48%
237,141 $5.51 Million
Q4 2022

Feb 14, 2023
BUY
$14.51 - $20.99 $88,598 - $128,164
6,106 Added 2.58%
243,180 $3.53 Million
Q3 2022

Nov 14, 2022
SELL
$18.21 - $27.88 $168,588 - $258,113
-9,258 Reduced 3.76%
237,074 $4.52 Million
Q2 2022

Aug 22, 2022
BUY
$16.45 - $25.88 $74,123 - $116,615
4,506 Added 1.86%
246,332 $4.48 Million
Q1 2022

May 16, 2022
SELL
$22.67 - $28.01 $37,246 - $46,020
-1,643 Reduced 0.67%
241,826 $6.09 Million
Q4 2021

Feb 14, 2022
BUY
$24.13 - $32.63 $614,663 - $831,183
25,473 Added 11.69%
243,469 $6.72 Million
Q3 2021

Nov 15, 2021
BUY
$29.97 - $36.66 $259,150 - $316,999
8,647 Added 4.13%
217,996 $7.04 Million
Q2 2021

Aug 12, 2021
SELL
$25.39 - $32.61 $1.27 Million - $1.64 Million
-50,206 Reduced 19.34%
209,349 $6.4 Million
Q1 2021

May 17, 2021
BUY
$19.92 - $31.6 $255,513 - $405,333
12,827 Added 5.2%
259,555 $7.9 Million
Q4 2020

Feb 12, 2021
BUY
$12.16 - $19.77 $14,567 - $23,684
1,198 Added 0.49%
246,728 $4.88 Million
Q3 2020

Nov 13, 2020
BUY
$11.25 - $14.75 $11,205 - $14,691
996 Added 0.41%
245,530 $3.2 Million
Q2 2020

Aug 14, 2020
BUY
$10.69 - $16.49 $163,385 - $252,033
15,284 Added 6.67%
244,534 $2.77 Million
Q1 2020

May 14, 2020
SELL
$9.78 - $29.53 $4,166 - $12,579
-426 Reduced 0.19%
229,250 $3.28 Million
Q4 2019

Feb 13, 2020
BUY
$20.93 - $35.1 $411,714 - $690,452
19,671 Added 9.37%
229,676 $6.26 Million
Q3 2019

Nov 13, 2019
BUY
$22.08 - $47.08 $158,799 - $338,599
7,192 Added 3.55%
210,005 $6.01 Million
Q2 2019

Aug 14, 2019
BUY
$22.67 - $35.0 $132,778 - $204,995
5,857 Added 2.97%
202,813 $5.63 Million
Q1 2019

May 15, 2019
BUY
$26.93 - $34.7 $474,318 - $611,171
17,613 Added 9.82%
196,956 $6.54 Million
Q4 2018

Feb 15, 2019
BUY
$27.23 - $45.56 $367,278 - $614,513
13,488 Added 8.13%
179,343 $5.19 Million
Q3 2018

Nov 20, 2018
BUY
$37.57 - $50.34 $608,108 - $814,803
16,186 Added 10.81%
165,855 $7.65 Million
Q2 2018

Aug 10, 2018
BUY
$27.75 - $40.17 $227,744 - $329,675
8,207 Added 5.8%
149,669 $5.58 Million
Q1 2018

May 17, 2018
BUY
$28.83 - $41.01 $120,653 - $171,626
4,185 Added 3.05%
141,462 $4.19 Million
Q4 2017

Feb 13, 2018
BUY
$28.45 - $37.14 $3.91 Million - $5.1 Million
137,277
137,277 $4.72 Million

Others Institutions Holding MYGN

# of Institutions
228
Shares Held
92M
Call Options Held
297K
Put Options Held
20.7K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $807M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email